ValentinaNardiMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Assistant pathologist, Massachusetts General Hospital

Dr. Nardi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Nicolls Rd
Boston, MA 11794
Phone+1 617-726-2967

Fax+1 617-726-7474

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Molecular Genetic Pathology, 2012 - 2013
Massachusetts General HospitalFellowship, Hematopathology, 2010 - 2012
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2008 - 2012
Univ Genoa- Fac MedClass of 2000

PubMed

Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Hiroto Inaba, David Teachey, Colleen Annesley, Sandeep Batra, Jill Beck
Journal of the National Comprehensive Cancer Network. 2025-02-01
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB.
Carlos A Torres-Cabala, Julia Yescas, Yue Zhang, Auris Huen, Sumit Gaur
Blood Advances. 2025-01-18
Integration of clinical outcomes and molecular features in extramedullary disease in multiple myeloma.
Rie Nakamoto-Matsubara, Valentina Nardi, Nora Horick, Tsuyoshi Fukushima, Ryan S Han
Blood Cancer Journal. 2024-12-23

Abstracts/Posters

Pregnancy Outcomes, Risk Factors, and Gestational Cell Count Trends in Pregnant Women with Essential Thrombocythemia and Polycythemia Vera
Valentina Nardi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Clinical, Immunophenotypic and Genomic Findings Â of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Newly Characterized Mutation May Define a Novel Leukemia Subtype in KidsFebruary 24th, 2022
Newly Characterized Mutation May Define Novel Pediatric AML SubtypeFebruary 17th, 2022
Case 37-2019: A 20-Month-Old Boy with Severe AnemiaNovember 28th, 2019